Research & Development
Labcorp receives FDA approval for melanoma companion diagnostic
10 August 2026 - Labcorp (NYSE: LH), a provider of comprehensive laboratory services, disclosed on Monday that it has received U.S. Food and Drug Administration approval for its PGDx elio tissue compl...
Sobi partners with Innate Pharma to advance lacutamab in T-cell lymphoma
10 August 2026 - Biopharmaceutical company Swedish Orphan Biovitrum AB (Sobi) (STO:SOBI) and clinical-stage biotechnology company Innate Pharma SA (Euronext Paris:IPH) (Nasdaq:IPHA) announced on Monda...
Oculis signs agreement to acquire Privosegtor from Accure Therapeutics
10 August 2026 - Switzerland-based biopharmaceutical company Oculis Holding AG (NASDAQ:OCS) (XICE:OCS) announced on Monday that it has entered into an asset purchase agreement with Accure Therapeutics...
Biophytis receives Brazilian approval for Phase 2 obesity trial of BIO101
10 August 2026 - Clinical-stage biotechnology company Biophytis SA (Euronext Growth Paris:ALBPS) (OTC:BPTSY) announced on Monday that it has received approval from Brazil's National Health Survei...
ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon
10 August 2026 - Specialist drug discovery and development company ImmuPharma plc (LSE AIM: IMM) announced on Monday that it has selected Kymos Germany/Prolytic, part of Kymos Group, as its bioanalyti...
BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer
7 August 2026 - Swedish biotech company BioInvent International AB (STO:BINV) announced on Friday that the US Food and Drug Administration (FDA) has granted Fast Track designation to its first-in-clas...